ARCHIVES

Revlimid Maintenance Therapy Delayed Progression by 90%

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

UNM Cancer Center Appoints Four Leaders

May 24, 2013

Two Drugs Slow Progress Of Metastatic Prostate Cancer

June 29, 2001

NCI Begins PLCO Screening Trial

November 26, 1993

Obituary: Ellen Tobin, Consultant, Championed Patients’ Needs;

January 10, 2003

Regulations Threaten Clinical Trials Higgins contends

May 16, 1980

Study Supports Hypothesis On Mastectomy Timing

June 7, 1991